China Antidiabetics Market Research Report 2017

January 2017 | 107 pages | ID: C2639BE5C1EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antidiabetics

Revenue, means the sales value of Antidiabetics

This report studies Antidiabetics in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Novo Nordisk
• Sanofi
• Eli Lilly
• GlaxoSmithKline
• Merck
• MannKind
• Takeda
• Johnson & Johnson
• AstraZeneca
• Bristol-Myers Squibb
• Boehringer Ingelheim
• Novartis
• BIOTON
• Salix Pharmaceuticals
• AstraZeneca

Market Segment by Regions (provinces), covering

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Rapid Acting
• Long Acting
• Short Acting
• Others

Split by Application, this report focuses on consumption, market share and growth rate of Antidiabetics in each application, can be divided into

• Hospital
• Clinic

Contents

China Antidiabetics Market Research Report 2017

1 ANTIDIABETICS MARKET OVERVIEW

1.1 Product Overview and Scope of Antidiabetics
1.2 Antidiabetics Segment by Type
  1.2.1 China Production Market Share of Antidiabetics Type in 2015
  1.2.2 Rapid Acting
  1.2.3 Long Acting
  1.2.4 Short Acting
  1.2.5 Others
1.3 Applications of Antidiabetics
  1.3.1 Antidiabetics Consumption Market Share by Application in 2015
  1.3.2 Hospital
  1.3.3 Clinic
1.4 China Market Size (Value) of Antidiabetics (2011-2021)
1.5 China Antidiabetics Status and Outlook
1.6 Government Policies

2 CHINA ANTIDIABETICS MARKET COMPETITION BY MANUFACTURERS

2.1 China Antidiabetics Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Antidiabetics Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Antidiabetics Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Antidiabetics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidiabetics Market Competitive Situation and Trends
  2.5.1 Antidiabetics Market Concentration Rate
  2.5.2 Antidiabetics Market Share of Top 3 and Top 5 Manufacturers

3 CHINA ANTIDIABETICS MANUFACTURERS PROFILES/ANALYSIS

3.1 Novo Nordisk
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Antidiabetics Product Type, Application and Specification
    3.1.2.1 Rapid Acting
    3.1.2.2 Long Acting
  3.1.3 Novo Nordisk Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Sanofi
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Antidiabetics Product Type, Application and Specification
    3.2.2.1 Rapid Acting
    3.2.2.2 Long Acting
  3.2.3 Sanofi 107 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Eli Lilly
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Antidiabetics Product Type, Application and Specification
    3.3.2.1 Rapid Acting
    3.3.2.2 Long Acting
  3.3.3 Eli Lilly 123 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 GlaxoSmithKline
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Antidiabetics Product Type, Application and Specification
    3.4.2.1 Rapid Acting
    3.4.2.2 Long Acting
  3.4.3 GlaxoSmithKline Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Merck
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Antidiabetics Product Type, Application and Specification
    3.5.2.1 Rapid Acting
    3.5.2.2 Long Acting
  3.5.3 Merck Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 MannKind
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Antidiabetics Product Type, Application and Specification
    3.6.2.1 Rapid Acting
    3.6.2.2 Long Acting
  3.6.3 MannKind Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Takeda
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Antidiabetics Product Type, Application and Specification
    3.7.2.1 Rapid Acting
    3.7.2.2 Long Acting
  3.7.3 Takeda Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Johnson & Johnson
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Antidiabetics Product Type, Application and Specification
    3.8.2.1 Rapid Acting
    3.8.2.2 Long Acting
  3.8.3 Johnson & Johnson Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 AstraZeneca
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Antidiabetics Product Type, Application and Specification
    3.9.2.1 Rapid Acting
    3.9.2.2 Long Acting
  3.9.3 AstraZeneca Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 Bristol-Myers Squibb
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Antidiabetics Product Type, Application and Specification
    3.10.2.1 Rapid Acting
    3.10.2.2 Long Acting
  3.10.3 Bristol-Myers Squibb Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview
3.11 Boehringer Ingelheim
3.12 Novartis
3.13 BIOTON
3.14 Salix Pharmaceuticals
3.15 AstraZeneca

4 CHINA ANTIDIABETICS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Antidiabetics Capacity, Production and Growth (2011-2016)
4.2 China Antidiabetics Revenue and Growth (2011-2016)
4.3 China Antidiabetics Production, Consumption, Export and Import (2011-2016)

5 CHINA ANTIDIABETICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Antidiabetics Production and Market Share by Type (2011-2016)
5.2 China Antidiabetics Revenue and Market Share by Type (2011-2016)
5.3 China Antidiabetics Price by Type (2011-2016)
5.4 China Antidiabetics Production Growth by Type (2011-2016)

6 CHINA ANTIDIABETICS MARKET ANALYSIS BY APPLICATION

6.1 China Antidiabetics Consumption and Market Share by Application (2011-2016)
6.2 China Antidiabetics Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINAANTIDIABETICS MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Antidiabetics Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Antidiabetics Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Antidiabetics Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Antidiabetics Sales Price by Regions (Provinces)(2011-2016)
7.2 China Antidiabetics Consumption by Regions (Provinces)(2011-2016)
7.3 China Antidiabetics Production, Consumption, Export and Import (2011-2016)

8 ANTIDIABETICS MANUFACTURING COST ANALYSIS

8.1 Antidiabetics Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antidiabetics

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Antidiabetics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antidiabetics Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA ANTIDIABETICS MARKET FORECAST (2016-2021)

12.1 China Antidiabetics Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Antidiabetics Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Antidiabetics Production Forecast by Type (2016-2021)
12.4 China Antidiabetics Consumption Forecast by Application (2016-2021)
12.5 China Antidiabetics Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Antidiabetics Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Antidiabetics Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Antidiabetics Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Antidiabetics Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetics
Figure China Production Market Share of Antidiabetics by Type in 2015
Figure Product Picture of Rapid Acting
Table Major Manufacturers of Rapid Acting
Figure Product Picture of Long Acting
Table Major Manufacturers of Long Acting
Figure Product Picture of Short Acting
Table Major Manufacturers of Short Acting
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Antidiabetics Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure China Antidiabetics Revenue (Million USD) and Growth Rate (2011-2021)
Table China Antidiabetics Capacity of Key Manufacturers (2015 and 2016)
Table China Antidiabetics Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Antidiabetics Capacity of Key Manufacturers in 2015
Figure China Antidiabetics Capacity of Key Manufacturers in 2016
Table China Antidiabetics Production of Key Manufacturers (2015 and 2016)
Table China Antidiabetics Production Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetics Production Share by Manufacturers
Figure 2016 Antidiabetics Production Share by Manufacturers
Table China Antidiabetics Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Antidiabetics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Antidiabetics Revenue Share by Manufacturers
Table 2016 China Antidiabetics Revenue Share by Manufacturers
Table China Market Antidiabetics Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Antidiabetics Average Price of Key Manufacturers in 2015
Table Manufacturers Antidiabetics Manufacturing Base Distribution and Sales Area
Table Manufacturers Antidiabetics Product Type
Figure Antidiabetics Market Share of Top 3 Manufacturers
Figure Antidiabetics Market Share of Top 5 Manufacturers
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Antidiabetics Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Antidiabetics Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Antidiabetics Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Antidiabetics Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Antidiabetics Market Share (2011-2016)
Table MannKind Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MannKind Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure MannKind Antidiabetics Market Share (2011-2016)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Antidiabetics Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Antidiabetics Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Antidiabetics Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Antidiabetics Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Antidiabetics Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BIOTON Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Salix Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Antidiabetics Capacity, Production and Growth (2011-2016)
Figure China Antidiabetics Revenue (Million USD) and Growth (2011-2016)
Table China Antidiabetics Production, Consumption, Export and Import (2011-2016)
Table China Antidiabetics Production by Type (2011-2016)
Table China Antidiabetics Production Share by Type (2011-2016)
Figure Production Market Share of Antidiabetics by Type (2011-2016)
Figure 2015 Production Market Share of Antidiabetics by Type
Table China Antidiabetics Revenue by Type (2011-2016)
Table China Antidiabetics Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Antidiabetics by Type (2011-2016)
Figure 2015 Revenue Market Share of Antidiabetics by Type
Table China Antidiabetics Price by Type (2011-2016)
Figure China Antidiabetics Production Growth by Type (2011-2016)
Table China Antidiabetics Consumption by Application (2011-2016)
Table China Antidiabetics Consumption Market Share by Application (2011-2016)
Figure China Antidiabetics Consumption Market Share by Application in 2015
Table China Antidiabetics Consumption Growth Rate by Application (2011-2016)
Figure China Antidiabetics Consumption Growth Rate by Application (2011-2016)
Table China Antidiabetics Production by Regions (Provinces)(2011-2016)
Table China Antidiabetics Production Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetics Production Value by Regions (Provinces)(2011-2016)
Table China Antidiabetics Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetics Sales Price by Regions (Provinces)(2011-2016)
Table China Antidiabetics Consumption by Regions (Provinces)(2011-2016)
Table China Antidiabetics Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetics Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetics
Figure Manufacturing Process Analysis of Antidiabetics
Figure Antidiabetics Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetics Major Manufacturers in 2015
Table Major Buyers of Antidiabetics
Table Distributors/Traders List
Figure China Antidiabetics Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Antidiabetics Revenue and Growth Rate Forecast (2016-2021)
Table China Antidiabetics Production, Import, Export and Consumption Forecast (2016-2021)
Table China Antidiabetics Production Forecast by Type (2016-2021)
Table China Antidiabetics Consumption Forecast by Application (2016-2021)
Table China Antidiabetics Production Forecast by Regions (Provinces)(2016-2021)
Table China Antidiabetics Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Antidiabetics Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)